Steven Cohen Repligen Corp Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Repligen Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 541,427 shares of RGEN stock, worth $68.3 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
541,427
Previous 596,895
9.29%
Holding current value
$68.3 Million
Previous $107 Million
7.21%
% of portfolio
0.25%
Previous 0.27%
Shares
22 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$980 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$643 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$450 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$222 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$185 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....